Home/Hedge Fund Intelligence/Aktis Oncology, Inc.
Nasdaq: AKTSStockForm 13F30 Jun 2026

Hedge funds that hold Aktis Oncology, Inc. Nasdaq: AKTS

CUSIP 01021M104 · who reports it, how much, and how much it matters to them

14 of the 720 hedge fund managers we track reported shares of Aktis Oncology, Inc. (Nasdaq: AKTS) on Form 13F for 30 June 2026. Between them they reported USD 328m. The largest position belongs to ECOR1 Capital, at USD 155m.

Managers reporting it14of 720 we track
Value they reportUSD 328mshares only, 30 Jun 2026
Funds they run133with a file on PPLI.com
Largest positionUSD 155mECOR1 Capital
Typical weight0.0%median share of a manager's book
Heaviest weight7.6%ECOR1 Capital

Compiled from SEC Form 13F filings · Hedge Fund Intelligence, PPLI.com · updated

Form 13F is filed by the manager and covers all of its accounts, so a position here belongs to the firm, not to any one fund. Not investment advice.

13F
What this page is

A list of every manager in our coverage that reported this share at the end of the quarter, taken from the filings themselves. Short positions and options are not in it.

Who holds it

14 managers, USD 328m between them

Taken from each manager's Form 13F for 30 June 2026. A manager appears here if it reported the shares themselves; positions held only through options are left out.

Every manager that reports Aktis Oncology, Inc., largest position first

The bar and the percentage show how much of the manager's reported 13F book the position makes up. Each name opens that manager's largest fund on PPLI.com, where the rest of its book is listed.

#ManagerValue reportedShare of its book
1ECOR1 Capital3 funds on PPLI.comUSD 155m7.6%
2RTW Investments2 funds on PPLI.comUSD 51m0.4%
3Ra Capital Management1 fund on PPLI.comUSD 42m0.4%
4Baker Bros. Advisors2 funds on PPLI.comUSD 32m0.2%
5Octagon Capital Advisors1 fund on PPLI.comUSD 31m2.8%
6Arrowmark Colorado Holdings24 funds on PPLI.comUSD 7.9m0.3%
7Renaissance Technologies13 funds on PPLI.comUSD 3.1m0.0%
8Squarepoint Ops7 funds on PPLI.comUSD 1.2m0.0%
9Sofinnova Investments1 fund on PPLI.comUSD 1m0.1%
10Two Sigma Investments35 funds on PPLI.comUSD 996,0000.0%
11Citadel Advisors32 funds on PPLI.comUSD 823,0000.0%
12Tudor Investment Corporation10 funds on PPLI.comUSD 690,0000.0%
13The Quarry1 fund on PPLI.comUSD 1,0960.0%
14Freestone Grove Partners1 fund on PPLI.comUSD 640.0%
Next: where it matters most
Where it matters most

For ECOR1 Capital it is 7.6% of the book

A large manager can hold a great deal of a share and barely notice it. This table turns the question round and ranks managers by how much of their own book the position takes up.

#ManagerValue reportedShare of its book
1ECOR1 CapitalUSD 155m7.6%
2Octagon Capital AdvisorsUSD 31m2.8%
3RTW InvestmentsUSD 51m0.4%
4Ra Capital ManagementUSD 42m0.4%
5Arrowmark Colorado HoldingsUSD 7.9m0.3%
6Baker Bros. AdvisorsUSD 32m0.2%
7Sofinnova InvestmentsUSD 1m0.1%
8Renaissance TechnologiesUSD 3.1m0.0%
9Squarepoint OpsUSD 1.2m0.0%
10Two Sigma InvestmentsUSD 996,0000.0%
Next: how to read this
How to read this

What a 13F list can and cannot tell you

  • It is the manager's filing, not a fund's. Form 13F covers every account a firm runs. We cannot say which of its funds holds the shares.
  • It is a snapshot. The list shows the last day of the quarter. A manager may have bought or sold since, and trading inside the quarter leaves no trace.
  • It shows one side. Short positions, swaps and shares listed outside the United States are not reported, so a manager on this list may be hedged or net short.
  • It covers the managers we track. Our coverage is 720 managers of hedge and private funds. Banks, index funds and other institutions that file Form 13F are not counted here.
Next: questions
Questions

Questions about who holds Aktis Oncology, Inc.

What is the ticker symbol of Aktis Oncology, Inc.?

Aktis Oncology, Inc. trades under the symbol AKTS on the Nasdaq. Its CUSIP, the code used on Form 13F, is 01021M104.

Which hedge funds own Aktis Oncology, Inc. (Nasdaq: AKTS)?

14 of the 720 hedge fund managers PPLI.com tracks reported Aktis Oncology, Inc. shares on Form 13F for 30 June 2026. The largest reported positions were held by ECOR1 Capital (USD 155m), RTW Investments (USD 51m), Ra Capital Management (USD 42m), Baker Bros. Advisors (USD 32m) and Octagon Capital Advisors (USD 31m).

How many hedge funds hold Aktis Oncology, Inc.?

14 managers in our coverage reported it, and between them they run 133 funds with a file on PPLI.com. The count is of managers, because Form 13F is filed by the firm and not by each fund.

Which manager has the most riding on Aktis Oncology, Inc.?

ECOR1 Capital, where the position was 7.6% of the reported 13F book at 30 June 2026.

Does this show who is short Aktis Oncology, Inc.?

No. Form 13F reports long positions in U.S.-listed shares and options. Short positions are not disclosed in it.

Important information

Positions are taken by PPLI.com from Form 13F filings with the U.S. Securities and Exchange Commission for the quarter shown. They are reported by each manager, cover all of its accounts and may have changed since. PPLI.com has no relationship with Aktis Oncology, Inc. or with the managers listed.

Nothing here is investment, tax or legal advice, a recommendation, or an offer or solicitation to buy or sell any security. To report an error, write to the editor.

Private consultation →
Step 1 of 2

Tell us about yourself

Read our Privacy Policy before submitting. Share only the information needed to describe your question; do not include medical records or account credentials.

✦Research assistant
✦PPLI.comResearch assistant
Explore PPLI questions and suitability factors
Ask a general question about PPLI, or explore the factors that affect suitability. Treat the answer as a starting point and check the linked sources.
Use the research with your own tax, legal and insurance advisers.
Preparing an answer
AI assistant. Educational information only. It does not determine eligibility or provide personal tax, legal, investment or insurance advice.